The Science of Salt: A Systematic Review of Quality Clinical Salt Outcome Studies June 2014 to May 2015

Journal of Clinical Hypertension

Volumn 18, Issue 9, 2016, Pages 832-839

  Johnson, Claire ^a   Raj, Thout Sudhir ^b   Trieu, Kathy ^a   Arcand, JoAnne ^c   Wong, Michelle M Y ^d   McLean, Rachael ^e   Leung, Alexander ^f   Campbell, Norm R C ^g   Webster, Jacqui ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^c UNIVERSITY OF ONTARIO INSTITUTE OF TECHNOLOGY   (Canada)

^d ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

^e UNIVERSITY OF OTAGO   (New Zealand)

^f UNIVERSITY OF CALGARY   (Canada)

^g UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADVERSE OUTCOME; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; COHORT ANALYSIS; EVIDENCE BASED MEDICINE; HEADACHE; HEALTH HAZARD; HUMAN; HYPERTENSION; MEDICAL RESEARCH; META ANALYSIS; METHODOLOGY; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SALT INTAKE; SODIUM INTAKE; SODIUM RESTRICTION; SYSTEMATIC REVIEW;

EID: 84988504126     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12877     Document Type: Article

References (47)

1. Asaria P, Chisholm D, Mathers C, et al. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet. 2007;370:2044–2053.
2. Institute for Health Metrics and Evaluation (IHME). GBD Compare. http://vizhub.healthdata.org/gbd-compare. Accessed Dec 22, 2015.
3. World Health Organisation. Reducing salt intake in populations: report of a WHO forum and technical meeting 5–7 October 2006. 2007 Paris 2007.
4. World Health Organisation. Draft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases: Formal Meeting of Member States to conclude the work on the comprehensive global monitoring framework, including indicators, and a set of voluntary global targets for the prevention and control of noncommunicable diseases. A/NCD/INF./1. November 5–7; 2012.
5. Stolarz-Skrzypek K, Kuznetsova T, Thijs L, et al. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA. 2011;305:1777–1785.
6. Taylor R, Ashton K, Moxham T, et al. Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review). Am J Hypertens. 2011;24:843–853.
7. Huang L, Crino M, Wu J, et al. Mean population salt intake estimated from 24-h urine samples and spot urine samples: a systematic review and meta-analysis. Int J Epidemiol 2016;45:239–250.
8. Campbell N, Appel L, Cappuccio F, et al. A call for quality research on salt intake and health: from the World Hypertension League and supporting organizations. J Clin Hypertens (Greenwich). 2014;16:469–471.
9. Johnson C, Raj T, Trudeau L, et al. The science of salt: a systematic review of clinical salt studies 2013 to 2014. J Clin Hypertens (Greenwich). 2015;17:401–411.
10. Arcand J, Webster J, Johnson C, et al. Announcing “Up to Date in the Science of Sodium.” J Clin Hypertens (Greenwich). 2016; 18: 85–88.
11. Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies. NIH National Heart, Lung and Blood Institute; 2014.
12. Shea B, Grimshaw J, Wells G, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7:1.
13. Graudal N, Jürgens G, Baslund B, Alderman M. Compared with usual sodium intake, low-and excessive-sodium diets are associated with increased mortality: a meta-analysis. Am J Hypertens. 2014;27:1129–1137.
14. Ahn S, Kim S, Kim D, et al. Urinary sodium excretion has positive correlation with activation of urinary renin angiotensin system and reactive oxygen species in hypertensive chronic kidney disease. J Korean Med Sci. 2014;29(Suppl 2):S123–S130.
15. Hwang J, Chin H, Kim S, et al. Effects of intensive low-salt diet education on albuminuria among nondiabetic patients with hypertension treated with olmesartan: a single-blinded randomized, controlled trial. Clin J Am Soc Nephrol. 2014;9:2059–2069.
16. Nerbass F, Pecoits-Filho R, McIntyre N, et al. Demographic associations of high estimated sodium intake and frequency of consumption of high-sodium foods in people with chronic kidney disease stage 3 in England. J Ren Nutr. 2014;24:236–242.
17. Jonsdottir S, Brader L, Gunnarsdottir I, et al. Adherence to the Nordic Nutrition Recommendations in a Nordic population with metabolic syndrome: high salt consumption and low dietary fibre intake (The SYSDIET study). Food Nutr Res. 2013;57: 10.3402/fnr.v57i0.21391.
18. Sakaki M, Tsuchihashi T, Arakawa K, et al. Long-term variability of urinary salt excretion and blood pressure in hypertensive patients. Hypertens Res. 2014;37:939–943.
19. Horikawa C, Yoshimura Y, Kamada C, et al. Dietary sodium intake and incidence of diabetes complications in Japanese patients with type 2 diabetes: analysis of the Japan Diabetes Complications Study (JDCS). J Clin Endocrinol Metab. 2014;99:3635–3643.
20. Engelen L, Soedamah-Muthu S, Geleijnse J, et al. Higher dietary salt intake is associated with microalbuminuria, but not with retinopathy in individuals with type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetologia. 2014;57:2315–2323.
21. Smyth A, Dunkler D, Gao P, et al. The relationship between estimated sodium and potassium excretion and subsequent renal outcomes. Kidney Int. 2014;86:1205–1212.
22. Farez M, Fiol M, Gaitán M, et al. Sodium intake is associated with increased disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry 2015;86:26–31.
23. Fan L, Tighiouart H, Levey A, et al. Urinary sodium excretion and kidney failure in nondiabetic chronic kidney disease. Kidney Int. 2014;86:582–588.
24. Merino J, Guasch-Ferré M, Martínez-González MA, et al. Is complying with the recommendations of sodium intake beneficial for health in individuals at high cardiovascular risk? Findings from the PREDIMED study. Am J Clin Nutr. 2015;101:440–448.
25. Markota N, Rumboldt M, Rumboldt Z. Emphasized warning reduces salt intake: a randomized controlled trial. J Am Soc Hypertens. 2015;9:214–220.
26. Wang Y, Liu F, Wang D, et al. Effect of salt intake and potassium supplementation on serum renalase levels in Chinese adults: a randomized trial. Medicine (Baltimore). 2014;93:e44.
27. Amer M, Woodward M, Appel LJ. Effects of dietary sodium and the DASH diet on the occurrence of headaches: results from randomised multicentre DASH-Sodium clinical trial. BMJ Open. 2014;4:e006671.
28. Singer P, Cohen H, Alderman M. Assessing the associations of sodium intake with long-term all-cause and cardiovascular mortality in a hypertensive cohort. Am J Hypertens. 2015;28:335–342.
29. Poggio R, Gutierrez L, Matta MG, et al. Daily sodium consumption and CVD mortality in the general population: systematic review and meta-analysis of prospective studies. Public Health Nutr. 2014;22:1–10.
30. Cooper W, Glover D, Hormbrey J, Kimber G. Headache and blood pressure: evidence of a close relationship. J Hum Hypertens. 1989;3:41–44.
31. Djamgoz M. Blood pressure and risk of cancer progression–a possible connection with salt and voltage-gated sodium channel. Med Hypotheses. 2015;85:591–593.
32. Deckers I, van den Brandt P, van Engeland M, et al. Long-term dietary sodium, potassium and fluid intake; exploring potential novel risk factors for renal cell cancer in the Netherlands Cohort Study on diet and cancer. Br J Cancer. 2014;110:797–801.
33. Park J, Kim Y, Koo H, et al. Estimated amount of 24-hour urine sodium excretion is positively correlated with stomach and breast cancer prevalence in Korea. J Korean Med Sci. 2014;29(Suppl 2):S131–S138.
34. Wang X, Terry P, Yan H. Review of salt consumption and stomach cancer risk: epidemiological and biological evidence. World J Gastroenterol. 2009;15:2204–2213.
35. Graudal N, Hubeck-Graudal T, Jurgens G. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database Syst Rev. 2011;(11):CD004022.
36. IOM. Institute of Medicine Committee on Public Health Priorities to Reduce and Control Hypertension, Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension. Washington, DC 2010.
37. Ji C, Sykes L, Paul C, et al. Systematic review of studies comparing 24-hour and spot urine collections for estimating population salt intake. Revista Panamericana de Salud Pública. 2012;32:307–315.
38. McLean R, Williams S, Mann J. Monitoring population sodium intake using spot urine samples: validation in a New Zealand population. J Hum Hypertens. 2014;28:657–662.
39. Majoor C, Vogt L. Can sodium excretion from single fasting morning urine really be used for estimation of dietary sodium intake? J Hypertens. 2014;32:2500–2501.
40. Pan American Health Organization. Salt-Smart Americas: A Guide for Country-Level Action. Washington, DC: PAHO; 2013.
41. Campbell N. Questionable scientific basis for relaxed dietary sodium recommendations. Can J Cardiol. 2016. doi: 10.1016/j.cjca.2015.10.027 [Epub ahead of print]
42. Campbell N, Lackland D, Niebylski M, Nilsson P. Is reducing dietary sodium controversial? Is it the conduct of studies with flawed research methods that is controversial? A perspective from the World Hypertension League Executive Committee. J Clin Hypertens (Greenwich). 2015;17:85–86.
43. He F, Ivkovic V, Jelakovic B, et al. Estimation of sodium excretion should be made as simple as possible, but not simpler: misleading papers and editorial on spot urines. J Hypertens. 2015;33:884–886.
44. Peng Y, Li W, Wang Y, et al. Validation and assessment of three methods to estimate 24-h urinary sodium excretion from spot urine samples in Chinese adults. PLoS One. 2016;11:e0149655.
45. Cogswell M, Maalouf J, Elliott P, et al. Use of urine biomarkers to assess sodium intake: challenges and opportunities. Annu Rev Nutr. 2015;35:349–387.
46. Cook N, Appel L, Whelton P. Lower levels of sodium intake and reduced cardiovascular risk. Circulation. 2014; 129 : 981–989.
47. Law M, Frost C, Wald N. By how much does dietary salt reduction lower blood pressure? III–Analysis of data from trials of salt reduction. BMJ. 1991;302:819–824.